STTK
Shattuck Labs IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$530.58M
P/E Ratio
—
EPS
$-0.73
Beta
1.29
52W High
$7.04
52W Low
$0.71
50-Day MA
$4.94
200-Day MA
$2.74
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Shattuck Labs Inc
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $1.00M |
| Gross Profit (TTM) | $-1.95M |
| EBITDA | $-47.74M |
| Operating Margin | -5143.00% |
| Return on Equity | -60.30% |
| Return on Assets | -35.30% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.30 |
| Price-to-Book | 5.58 |
| Price-to-Sales (TTM) | 530.58 |
| EV/Revenue | 383.8 |
| EV/EBITDA | -3.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -66.60% |
| Shares Outstanding | $75.58M |
| Float | $46.22M |
| % Insiders | 9.76% |
| % Institutions | 67.31% |
Historical Volatility
HV 10-Day
61.71%
HV 20-Day
48.48%
HV 30-Day
73.72%
HV 60-Day
68.07%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.00 target)
1
Strong Buy3
Buy2
HoldData last updated: 4/9/2026